Researchers Find New Way to Curb Asthma Attacks
By Dennis Thompson HealthDay Reporter
TUESDAY, March 26, 2025 -- A protein that shuts down immune cells in the lungs could be key to a new treatment for asthma attacks, a new report says.
The naturally occurring protein, called Piezo1, prevents a type of immune cell called type 2 innate lymphoid cells (ILC2s) from becoming hyperactivated by allergens.
An experimental drug called Yoda1 that switches on Piezo1 reduced the activity of these immune cells in mice, alleviating asthma symptoms, researchers report.
“Given the importance of ILC2s in allergic asthma, there is an urgent need to develop novel mechanism-based approaches to target these critical drivers of inflammation in the lungs,” researcher Omid Akbari, a professor at the University of Southern California’s Keck School of Medicine, said in a news release.
Once triggered by an allergen, ILC2s drive the inflammatory cascade that cause airways to swell and tighten, making it tough for asthma patients to draw breath.
In mouse research, researchers found that activated ILC2s naturally produce a protein called Piezo1 that limits their activity.
In the absence of Piezo1, mouse ILC2s became more responsive to allergy signals and promoted even more airway inflammation.
On the other hand, Yoda1 caused Piezo1 to kick into action, reducing the activity of ILC2s.
Human ILC2s also produce Piezo1, researchers say, and the drug Yoda1 also worked on lab-engineered mice with the human immune cells.
“Remarkably, treatment of these humanized mice with Yoda1 reduced airway hyperreactivity and lung inflammation, suggesting that Yoda1 may be used as a therapeutic tool to modulate ILC2 function and alleviate the symptoms associated with ILC2-dependent airway inflammation in humans,” Akbari said.
He said future research should focus on developing specific drugs to control Piezo1 in humans, which might help control or head off allergic asthma attacks.
The new study appears in the Journal of Experimental Medicine.
Sources
- Journal of Experimental Medicine, news release, March 26, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Too Few Asthma Patients Are Using Updated Inhalers
WEDNESDAY, May 22, 2024 -- Improved inhalers are now available to help control asthma and treat sudden attacks, but a new study shows that hardly anyone’s using them. The...
More Kids With Asthma Need Hospital Care on Very Hot Days
TUESDAY, May 21, 2024 -- Heat waves and heat domes are particularly dangerous to kids with asthma, a new study finds. Daytime heat waves are associated with 19% increased odds...
Vaping Linked to Earlier Onset of Asthma
FRIDAY, May 17, 2024 -- People with asthma who vape tend to develop the respiratory disease earlier in life than folks who never vaped, new research shows. Overall, asthmatic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
